3. Summary
Global Markets Direct’s, Pituitary ACTH Hypersecretion (Cushings Disease) -
Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic
pipeline. This report provides information on the therapeutic development for
Pituitary ACTH Hypersecretion (Cushings Disease), complete with latest
updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Pituitary ACTH
Hypersecretion (Cushings Disease). Pituitary ACTH Hypersecretion (Cushings
Disease) - Pipeline Review, Half Year is built using data and information sourced
from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together
by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Pituitary ACTH Hypersecretion
(Cushings Disease).
- A review of the Pituitary ACTH Hypersecretion (Cushings Disease) products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Pituitary ACTH Hypersecretion (Cushings Disease).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
5. Table of Contents :
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Pituitary ACTH Hypersecretion (Cushings Disease) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Pituitary ACTH Hypersecretion
(Cushings Disease) 7
Pituitary ACTH Hypersecretion (Cushings Disease) Therapeutics under
Development by Companies 9
Pituitary ACTH Hypersecretion (Cushings Disease) Therapeutics under
Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Pituitary ACTH Hypersecretion (Cushings Disease) Therapeutics – Products
under Development by Companies 14………..
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?searc
h=Pipeline Review, H2 2012&PubId=&pagenum=1